Although the transfer of activated whole spleen cells delayed skin tumor growth, the transfer of ex vivo—expanded CD4+ T cells and CD8+ T cells strongly inhibited tumor progression (Fig 2A). The gene discussed is CD4; the disease is skin neoplasm.